India: Food, Drugs, Healthcare, Life Sciences

The landscape of food safety and public health in India is facing escalating challenges. A burgeoning population coupled with rapid urbanization and evolving dietary patterns has led to a surge in the consumption of processed and packaged foods.

Denial or grant of injunction in a patent infringement dispute in Indian courts or elsewhere on the ground of public interest is not a new trend.

On 28 April 2025, The Advertising Standards Council of India (ASCI) has issued a press release (Press Release) on its website, indicating an update to the ASCI Guidelines for Influencer Advertising in Digital Media (Guidelines) in the domain of health, nutrition, and financial services (Addendum II).

Learn about GST rates on medicines in India, from 0% to 12%, covering essential drugs, Ayurvedic treatments, and their impact on pricing and the healthcare sector.

The burgeoning biotechnology sector in India presents a fertile ground for foreign investments, particularly from Russian enterprises.

Over the past couple of months, the Central Drugs Standard Control Organisation has been actively streamlining licensing and approval requirements for pharmaceutical companies...

The landscape of food safety and public health in India is facing escalating challenges. A burgeoning population coupled with rapid urbanization and evolving dietary patterns has led to a surge in the consumption of processed and packaged foods.

Access to affordable medical care is a fundamental right of every human being. From the perspective of patent law, in India, generally the focus has been on pharmaceutical drugs and how patent law can balance the right of public to affordable drugs viz-a-viz the right of innovators.

The Calcutta High Court, in a recent decision involving ITC, tested the extent to which the public health exception contained in Section 3(b) of the Patents Act, 1970, can be used to reject an application for a patent.